Form 4 for LTRN Lantern Pharma Inc.
Accepted 2024-07-26 00:00:00 ET · period of report 2024-07-24 · accession 0001493152-24-029238 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-26 | 2024-07-24 | LTRN | KEYSER D JEFFREY | Dir | X - OptEx | $3.13 | +3,832 | 0 | New | +$12.0K |
| D | 2024-07-26 | 2024-07-24 | LTRN | KEYSER D JEFFREY | Dir | X - OptEx | $0.00 | -3,832 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-07-24 | X | A | 3,832 | $3.13 | 0 | D | — | — | |
| 2 | Derivative | Series A Warrants | 2024-07-24 | X | D | 3,832 | $0.00 | 0 | D | $3.13 · 2019-07-25 to 2024-07-25 | 3,832 Common Stock |